


Ask a doctor about a prescription for Sintrom
Acenocoumarol
Sintrom contains the active substance acenocoumarol.
Acenocoumarol belongs to a group of anticoagulant substances that reduce the blood's ability to clot and thus prevent the formation of blood clots in blood vessels.
Sintrom is indicated for the treatment and prevention of thromboembolic diseases.
Sintrom works by inhibiting the formation of blood clots. It does not dissolve blood clots that have already formed, but it can prevent clots from growing and causing more serious problems.
During treatment with Sintrom, the doctor will prescribe regular blood tests and adjust the dose of the medicine accordingly.
You should consult your doctor if you have any questions about the action of Sintrom or the reasons why it was prescribed.
Sintrom should only be taken after consulting a doctor. Sintrom is not suitable for every patient.
You should strictly follow the doctor's instructions, which may differ from the information contained in this leaflet.
If any of the above situations occur, you should contact your doctor before taking Sintrom.
You should consult your doctor for advice if you have an allergy.
Before starting Sintrom, you should discuss the following with your doctor:
You should immediately tell your doctor if any of the above situations occur.
Data on the use of Sintrom in children and adolescents are limited, and therefore, more frequent control tests are necessary.
Patient over 65 years old may be more sensitive to acenocoumarol, and therefore, more frequent control tests and, if necessary, dose reduction of the administered medicine may be required.
You should tell your doctor about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
Sintrom may affect the action of other medicines, and vice versa.
It is recommended that Sintrom not be taken with any of the above-mentioned medicines. If it is necessary to take any of these medicines while taking Sintrom, the doctor will more frequently monitor the blood clotting parameters.
Other medicines that may increase the effect of Sintrom, such as:
You should limit your consumption of large amounts of alcohol and foods rich in vitamin K, such as leafy green vegetables, spinach, cabbage, kale, peas, soybean oil, walnuts, broccoli, turnips, alfalfa, avocado, etc. Alcohol may alter the effect of Sintrom. If you are unsure, you should consult your doctor.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor or pharmacist before taking this medicine.
The use of Sintrom during pregnancy is contraindicated. Sintrom, like other anticoagulant medicines, may cause serious harm to the fetus.
It is recommended that women of childbearing age have a pregnancy test before taking Sintrom to rule out pregnancy. You should use effective contraception while taking Sintrom.
The potential risks and benefits of the therapy should be discussed with the patient by the doctor.
If you are breastfeeding, you should consult your doctor. Both the mother and the child require special medical supervision, and the child should prophylactically receive vitamin K.
Sintrom does not affect the ability to drive or use machines. In case of an accident, you should inform your doctor or hospital staff that you are taking Sintrom.
Considering the possibility of injury, e.g. in an accident, it is recommended to carry a card with information about anticoagulant treatment.
Sintrom contains lactose (milk sugar). If you have been diagnosed with intolerance to some sugars, you should contact your doctor before taking the medicine.
This medicine should always be taken according to the doctor's instructions. If you are unsure, you should consult your doctor.
The dosage of the medicine is determined by the doctor. Regular blood clotting tests allow the doctor to adjust the dose of Sintrom, which should be taken daily. You should follow the doctor's instructions and not exceed the recommended doses.
The doctor will inform you exactly how many Sintrom tablets to take. Depending on how you respond to the treatment, the doctor may recommend increasing or decreasing the dose.
Individual sensitivity to the medicine may vary and may change during treatment or when changing your diet, especially when foods rich in vitamin K (spinach, cabbage) are included. You should strictly follow the doctor's instructions, which will be based on laboratory tests and tailored to your needs.
Adults
The usual initial dose is 2 mg/day to 4 mg/day.
The maintenance dose is usually between 1 mg/day and 8 mg/day.
Elderly patients, patients with liver disease, or severe heart failure (which slows down blood flow in the liver and may damage it) or malnourished patients may require a lower dose at the beginning and during maintenance treatment with Sintrom.
Use in children and adolescents
The doctor will decide on the use of Sintrom in children and adolescents.
You should regularly take the tablets, every day at the same time (e.g. in the evening with a meal, with a glass of water). The tablets should be swallowed whole.
The tablet can be divided into equal doses.
The doctor should assess whether the patient is able to divide the Sintrom tablet, 4 mg, into four equal parts.
The doctor will inform you exactly how long to take Sintrom.
If you accidentally take more than the recommended amount of Sintrom tablets, you should immediately contact your doctor.Overdose of Sintrom may lead to bleeding. If bleeding occurs, you should stop taking Sintrom and start treatment for bleeding.
If you miss a dose, you should take the missed dose as soon as possible. If it is almost time for the next dose, you should not take the missed dose, just take the next dose at the usual time.
You should not take a double dose to make up for the missed dose. During your next visit to the doctor, you should inform them about all cases of missed doses.
If you have any further doubts about taking this medicine, you should consult your doctor.
Like all medicines, Sintrom can cause side effects, although not everybody gets them.
Frequent (less than 1 case in 10 people): bleeding (symptoms may include: unexplained nosebleeds or bleeding gums when brushing teeth; unexplained bruising; unusual, heavy, or unexpected menstrual bleeding; blood in urine; bloody or black, tarry stools; coughing up blood or bloody vomit; sudden, severe, or persistent headache). If you experience any of these bleeding symptoms, it may mean that you have taken more medicine than you need.
Rare (less than 1 case in 1,000 people): Allergic reactions in the form of a rash or itching.
Very rare (less than 1 case in 10,000 people): Blood spots in the skin with blistering or without blistering, usually located on the cheeks, buttocks, abdomen, chest, and sometimes on the toes; blood spots or hematomas under the skin (a sign of possible vasculitis).
If you experience any of the above side effects, you should immediately inform your doctor.
Rare (less than 1 case in 1,000 people): hair loss, decreased appetite, vomiting, nausea.
If you experience any of the above symptoms, you should inform your doctor.
Frequency not known (frequency cannot be estimated from the available data): Painful skin rash. Sintrom may cause severe skin disorders, including calciphylaxis, which may initially manifest as a painful skin rash but may lead to other serious complications. This side effect occurs more frequently in patients with chronic kidney disease.
Lower than normal red blood cell count or decreased hemoglobin levels (anemia).
If you experience any side effects not listed in this leaflet, you should tell your doctor.
If you experience any side effects, including any side effects not listed in the leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help gather more information on the safety of the medicine.
There are no special storage instructions.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging.
The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Sintrom is a white, round, flat tablet with rounded edges. On one side, it is engraved with "CG" and on the other side, it has a cross-shaped dividing line, allowing it to be divided into four equal parts, each with the letter "A" engraved.
Sintrom is available in packs containing 20 tablets.
For more detailed information, you should contact the marketing authorization holder or the parallel importer.
Merus Labs Luxco II S.à.R.L.
26-28, rue Edward Steichen
L-2540 Luxembourg
Luxembourg
FAMAR A.V.E.
Anthoussa Avenue 7
Anthoussa Attiki, 15349
Greece
NORGINE B.V.
Antonio Vivaldistraat 150
1083 HP, Amsterdam
Netherlands
ROVI PHARMA INDUSTRIAL SERVICES, S.A.
FROSST IBÉRICA, S.A.
Via Complutense, 140
Alcalá de Henares
28805 Madrid
Spain
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
CEFEA Sp. z o.o. Sp. komandytowa
ul. Działkowa 56
02-234 Warsaw
SHIRAZ PRODUCTIONS Sp. z o.o.
ul. Tymiankowa 24/28
95-054 Ksawerów
CANPOLAND SPÓŁKA AKCYJNA
ul. Beskidzka 190
91-610 Łódź
Marketing authorization number in Romania, the country of export: 2606/2010/01
Parallel import authorization number: 155/18
Date of leaflet approval: 08.02.2023
[Information about the trademark]
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Sintrom – subject to medical assessment and local rules.